Literature DB >> 24259003

Isolation of circulating microRNAs from microvesicles found in human plasma.

John F Quackenbush1, Pamela B Cassidy, Lawrence M Pfeffer, Kenneth M Boucher, Jason E Hawkes, Susan R Pfeffer, Levy Kopelovich, Sancy A Leachman.   

Abstract

Intact miRNAs can be isolated from the circulation in significant quantities despite the presence of extremely high levels of RNase activity. The remarkable stability of circulating miRNAs makes them excellent candidates for biomarkers in diagnostic applications as well as therapeutic targets in a variety of disease states including melanoma. Circulating RNA molecules are resistant to degradation by RNases because they are encapsulated in membrane-bound microvesicles. We describe a convenient method for the use of ExoQuick, a proprietary resin developed by Systems Biosciences (Mountain View, CA), whereby microvesicles can be purified under gentle conditions using readily available laboratory equipment. This protocol allows for isolation all microvesicles, regardless of their origin, and provides a convenient method for identifying potential cancer-specific biomarkers from biological fluids including serum and plasma.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24259003     DOI: 10.1007/978-1-62703-727-3_34

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  18 in total

1.  Extracellular vesicles of the blood-brain barrier: Role in the HIV-1 associated amyloid beta pathology.

Authors:  Ibolya E András; Ana Leda; Marta Garcia Contreras; Luc Bertrand; Minseon Park; Marta Skowronska; Michal Toborek
Journal:  Mol Cell Neurosci       Date:  2016-12-29       Impact factor: 4.314

2.  Exosomes in human semen restrict HIV-1 transmission by vaginal cells and block intravaginal replication of LP-BM5 murine AIDS virus complex.

Authors:  Marisa N Madison; Philip H Jones; Chioma M Okeoma
Journal:  Virology       Date:  2015-04-13       Impact factor: 3.616

3.  Human saliva-derived exosomes: comparing methods of isolation.

Authors:  Ayelet Zlotogorski-Hurvitz; Dan Dayan; Gavriel Chaushu; Johanna Korvala; Tuula Salo; Raija Sormunen; Marilena Vered
Journal:  J Histochem Cytochem       Date:  2014-12-03       Impact factor: 2.479

Review 4.  MicroRNAs: promising chemoresistance biomarkers in gastric cancer with diagnostic and therapeutic potential.

Authors:  Christiane Matuszcak; Joerg Haier; Richard Hummel; Kirsten Lindner
Journal:  World J Gastroenterol       Date:  2014-10-14       Impact factor: 5.742

5.  Deep dive on the proteome of salivary extracellular vesicles: comparison between ultracentrifugation and polymer-based precipitation isolation.

Authors:  Meng Li; Doudou Lou; Joyce Chen; Keqing Shi; Yong Wang; Qingfu Zhu; Fei Liu; Yating Zhang
Journal:  Anal Bioanal Chem       Date:  2020-11-07       Impact factor: 4.142

6.  Assay reproducibility in clinical studies of plasma miRNA.

Authors:  Jonathan Rice; Henry Roberts; James Burton; Jianmin Pan; Vanessa States; Shesh N Rai; Susan Galandiuk
Journal:  PLoS One       Date:  2015-04-08       Impact factor: 3.240

7.  Identification of the long non-coding RNA H19 in plasma as a novel biomarker for diagnosis of gastric cancer.

Authors:  Xiaoying Zhou; Chengqiang Yin; Yini Dang; Feng Ye; Guoxin Zhang
Journal:  Sci Rep       Date:  2015-06-22       Impact factor: 4.379

Review 8.  The impact of extracellular vesicle-encapsulated circulating microRNAs in lung cancer research.

Authors:  Yu Fujita; Kazuyoshi Kuwano; Takahiro Ochiya; Fumitaka Takeshita
Journal:  Biomed Res Int       Date:  2014-09-11       Impact factor: 3.411

9.  Human semen contains exosomes with potent anti-HIV-1 activity.

Authors:  Marisa N Madison; Richard J Roller; Chioma M Okeoma
Journal:  Retrovirology       Date:  2014-11-19       Impact factor: 4.602

10.  In silico identification of plant miRNAs in mammalian breast milk exosomes--a small step forward?

Authors:  Anna Lukasik; Piotr Zielenkiewicz
Journal:  PLoS One       Date:  2014-06-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.